Literature DB >> 17498583

Early increase of oxidative stress and soluble CD40L in children with hypercholesterolemia.

Francesco Martino1, Pasquale Pignatelli, Eliana Martino, Francesco Morrone, Roberto Carnevale, Serena Di Santo, Barbara Buchetti, Lorenzo Loffredo, Francesco Violi.   

Abstract

OBJECTIVES: The aim of the study was to analyze the behavior of oxidative stress and its interplay with CD40L, a protein that is implicated in atherosclerosis, in hypercholesterolemic children.
BACKGROUND: Oxidative stress has been suggested to play a major role in premature atherosclerosis.
METHODS: Forty-one children with hypercholesterolemia (mean age 9.28 +/- 0.5 years) and 40 children with normocholesterolemia (mean age 9.02 +/- 0.69 years) were matched for gender and age. Within each group, children were classified as having or not having a family history of cardiovascular disease. Serum levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), a marker of oxidative stress, and plasma levels of soluble CD40L (sCD40L) were measured in each child. In a subgroup of children with high (n = 8) or normal (n = 8) levels of serum cholesterol, platelet p38 mitogen-activated protein (MAP) kinase phosphorylation, a protein involved in the activation of nicotinamide adenine dinucleotide phosphate oxidase, was determined.
RESULTS: Children with hypercholesterolemia had higher values of 8-OHdG and sCD40L compared with control subjects (0.55 +/- 0.06 ng/ml vs. 0.21 +/- 0.02 ng/ml, p < 0.001 and 0.55 +/- 0.04 ng/ml vs. 0.19 +/- 0.03 ng/ml, p < 0.001, respectively). A significant correlation between 8-OHdG and sCD40L was observed in children with high (r = 0.676, p < 0.001) or normal (r = 0.878, p < 0.001) levels of cholesterol. Children with a family history of cardiovascular disease tended to have higher values of 8-OHdG and sCD40L, but the difference was not significant. Analysis of platelet p38 MAP kinase showed that it was phosphorylated more in children with hypercholesterolemia compared with control subjects (36.8 +/- 5.8 AU vs. 8.0 +/- 4.5 AU, p < 0.001 respectively).
CONCLUSIONS: Children with hypercholesterolemia have an early increase of oxidative stress that may be responsible for up-regulation of CD40L and potentially predispose to premature atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498583     DOI: 10.1016/j.jacc.2007.01.082

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  5 in total

1.  Oxidative stress and cardiovascular risk in overweight children in an exercise intervention program.

Authors:  B Adam Dennis; Adviye Ergul; Barbara A Gower; Jerry D Allison; Catherine L Davis
Journal:  Child Obes       Date:  2012-12-27       Impact factor: 2.992

Review 2.  Clinical significance of inflammation factors in acute coronary syndrome from pathogenic toxin.

Authors:  Yan Feng; Jing-chun Zhang; Rui-xi Xi
Journal:  Chin J Integr Med       Date:  2009-08-18       Impact factor: 1.978

3.  Different impacts of cardiovascular risk factors on oxidative stress.

Authors:  Maria L Mansego; Josep Redon; Sergio Martinez-Hervas; Jose T Real; Fernando Martinez; Sebastian Blesa; Veronica Gonzalez-Albert; Guillermo T Saez; Rafael Carmena; Felipe J Chaves
Journal:  Int J Mol Sci       Date:  2011-09-20       Impact factor: 5.923

4.  The Oxidative Stress-Induced miR-200c Is Upregulated in Psoriasis and Correlates with Disease Severity and Determinants of Cardiovascular Risk.

Authors:  A Magenta; M D'Agostino; S Sileno; L Di Vito; C Uras; D Abeni; F Martino; F Barillà; S Madonna; C Albanesi; M Napolitano; M C Capogrossi; G Melillo
Journal:  Oxid Med Cell Longev       Date:  2019-12-19       Impact factor: 6.543

5.  Early myocardial deformation changes in hypercholesterolemic and obese children and adolescents: a 2D and 3D speckle tracking echocardiography study.

Authors:  Antonio Vitarelli; Francesco Martino; Lidia Capotosto; Eliana Martino; Chiara Colantoni; Rasul Ashurov; Serafino Ricci; Ysabel Conde; Fabio Maramao; Massimo Vitarelli; Stefania De Chiara; Cristina Zanoni
Journal:  Medicine (Baltimore)       Date:  2014-09       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.